1. Main page
  2. Biotechnology
  3. NanoCarrier Co

NanoCarrier Co

4 Decision Makers · 4 Verified Contacts & Email Format

nanocarrier.co.jp
📍 Chiba, Chiba, JapanBiotechnology🗓 Est. 1996👥 11–50 employees

About NanoCarrier Co

NanoCarrier Co is a pharmaceutical company that researches and develops medical products by applying the micellar nanoparticle technology.

Email Format

{last_name}@nanocarrier.co.jp — 100.0%

smith@nanocarrier.co.jp

Leadership & Decision Makers

Contact details of 4 NanoCarrier Co decision makers

Ichiro Nakatomi

Founder, President & CEO

  • Work email

    n******i@nanocarrier.co.jp

Kazunori Kataoka

Founder

Teruo Okano

Founder

Tetsuhito Matsuyama

CFO and Head of President’s Office

General Emails

General company emails, e.g. customer support lines

    info@nanocarrier.co.jp

    General Inquiries

    bobe@nanocarrier.co.jp

    Unclassified inbox

Verify NanoCarrier Co Emails

Similar Companies like NanoCarrier Co

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees

HQ: Cambridge, MA

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Horizon Discovery

horizondiscovery.com
Pharmaceuticals · Cambridge, Cambridgeshire, United Kingdom · Est. 2007 · 101–250 employees

HQ: Cambridge, Cambridgeshire, United Kingdom

nference

nference.com
Biotechnology · Cambridge, MA · Est. 2013 · 251–500 employees

HQ: Cambridge, MA

Cytokinetics

cytokinetics.com
Pharmaceuticals · South San Francisco, California, United States · Est. 1998 · 251–500 employees · $50M–$100M

HQ: South San Francisco, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

nanocarrier.co.jp

+81471977622

Chiba, Chiba, Japan

Specialization: Nanotechnology,
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Debt
Founded Date: 1996
Company Type: For Profit
Stock Symbol: TYO:4571
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: +81471977622
Last Investment Activity: Sep 1, 2020
Investments Activity: Sep 1, 2020 Jan 17, 2018 Sep 18, 2015

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.